Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection - The double-edged sword?

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Hossain, Md Murad ^a   Norazmi, Mohd Nor ^a,b  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYTOKINE; DECTIN 1; GAMMA INTERFERON; HEAT SHOCK PROTEIN 65; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; MANNOSE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE; SURFACTANT PROTEIN A; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED PROTEIN KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL LOAD; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE RELEASE; DENDRITIC CELL; HEREDITY; IMMUNE EVASION; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE MIGRATION; MACROPHAGE ACTIVATION; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PHAGOCYTE; PHAGOCYTOSIS; PHAGOSOME; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; TISSUE NECROSIS; TUBERCULOSIS; ANIMAL; HUMAN; IMMUNOLOGY;

ANIMALS; CYTOKINES; HUMANS; IMMUNITY, INNATE; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, PATTERN RECOGNITION; TUBERCULOSIS;

EID: 84890074430     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/179174     Document Type: Review

References (213)

1. World Health Organization, Global tuberculosis control. 2010
2. Ahmad S., Pathogenesis, immunology, and diagnosis of latent mycobacterium tuberculosis infection. Clinical and Developmental Immunology 2011 2011 17 2-s2.0-79952225371 10.1155/2011/814943 814943
3. Korbel D. S., Schneider B. E., Schaible U. E., Innate immunity in tuberculosis: myths and truth. Microbes and Infection 2008 10 9 995 1004 2-s2.0-53449088427 10.1016/j.micinf.2008.07.039
4. Medzhitov R., Janeway C. J. Jr., The Toll receptor family and microbial recognition. Trends in Microbiology 2000 8 10 452 456 2-s2.0-0034307339 10.1016/S0966-842X(00)01845-X
5. Kaisho T., Akira S., Critical roles of Toll-like receptors in host defense. Critical Reviews in Immunology 2000 20 5 393 405 2-s2.0-0034485512 (Pubitemid 32104093)
6. Takeda K., Kaisho T., Akira S., Toll-like receptors. Annual Review of Immunology 2003 21 335 376 2-s2.0-0012929728 10.1146/annurev.immunol.21.120601. 141126 (Pubitemid 37174535)
7. Aderem A., Ulevitch R. J., Toll-like receptors in the induction of the innate immune response. Nature 2000 406 6797 782 787 2-s2.0-0034680145 10.1038/35021228
8. Flynn J. L., Chan J., Immunology of tuberculosis. Annual Review of Immunology 2001 19 93 129 2-s2.0-0035064072 10.1146/annurev.immunol.19.1.93 (Pubitemid 32368031)
9. Flynn J. L., Chan J., Immune evasion by Mycobacterium tuberculosis: living with the enemy. Current Opinion in Immunology 2003 15 4 450 455 2-s2.0-0041402773 10.1016/S0952-7915(03)00075-X (Pubitemid 36930083)
10. Bhatt K., Salgame P., Host innate immune response to Mycobacterium tuberculosis. Journal of Clinical Immunology 2007 27 4 347 362 2-s2.0-34250222782 10.1007/s10875-007-9084-0 (Pubitemid 46906653)
11. Kleinnijenhuis J., Oosting M., Joosten L. A. B., Netea M. G., van Crevel R., Innate immune recognition of mycobacterium tuberculosis. Clinical and Developmental Immunology 2011 2011 12 2-s2.0-79959246255 10.1155/2011/405310 405310
12. van Crevel R., Ottenhoff T. H. M., van der Meer J. W. M., Innate immunity to Mycobacterium tuberculosis. Clinical Microbiology Reviews 2002 15 2 294 309 2-s2.0-0036222899 10.1128/CMR.15.2.294-309.2002 (Pubitemid 34303767)
13. Zuniga J., Torres-Garcia D., Santos-Mendoza T., Rodriguez-Reyna T. S., Granados J., Yunis E. J., Cellular and humoral mechanisms involved in the control of tuberculosis. Clinical & Developmental Immunology 2012 2012 18 10.1155/2012/193923 193923
14. Li Y., Wang Y., Liu X., The role of airway epithelial cells in response to mycobacteria infection. Clinical & Developmental Immunology 2012 2012 11 791392 10.1155/2012/791392
15. Saiga H., Shimada Y., Takeda K., Innate immune effectors in mycobacterial infection. Clinical and Developmental Immunology 2011 2011 8 2-s2.0-79952220311 10.1155/2011/347594 347594
16. Tsolaki A. G., Innate immune recognition in tuberculosis infection. Advances in Experimental Medicine and Biology 2009 653 185 197 2-s2.0-70350500674 10.1007/978-1-4419-0901-5-13
17. Wolf A. J., Desvignes L., Linas B., Banaiee N., Tamura T., Takatsu K., Ernst J. D., Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs. The Journal of Experimental Medicine 2008 205 1 105 115 2-s2.0-38749138163 10.1084/jem.20071367 (Pubitemid 351185719)
18. Tufariello J. M., Chan J., Flynn J. L., Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infectious Diseases 2003 3 9 578 590 2-s2.0-0042863345 10.1016/S1473-3099(03)00741-2 (Pubitemid 37064537)
19. Flynn J. L., Chan J., What's good for the host is good for the bug. Trends in Microbiology 2005 13 3 98 102 2-s2.0-14644408757 10.1016/j.tim.2005. 01.005 (Pubitemid 40311891)
20. Hernandez-Pando R., Pavön L., Arriaga K., Orozco H., Madrid-Marina V., Rook G., Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection. Infection and Immunity 1997 65 8 3317 3327 2-s2.0-0030760776 (Pubitemid 27342417)
21. Power C. A., Wei G., Bretscher P. A., Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infection and Immunity 1998 66 12 5743 5750 2-s2.0-0031740995 (Pubitemid 28531829)
22. Elias D., Britton S., Kassu A., Akuffo H., Chronic helminth infections may negatively influence immunity against tuberculosis and other diseases of public health importance. Expert Review of Anti-Infective Therapy 2007 5 3 475 484 2-s2.0-34447291089 10.1586/14787210.5.3.475 (Pubitemid 47050167)
23. Rook G., Nor N., Acosta A., Elena Sarmiento M., Tuberculosis in developing countries due to high-dose challenge in partially immune individuals. The Art and Science of Tuberculosis Vaccine Development 2010 chapter 28 Oxford Fajar
24. Bellamy R., Susceptibility to mycobacterial infections: the importance of host genetics. Genes and Immunity 2003 4 1 4 11 2-s2.0-0038805137 10.1038/sj.gene.6363915 (Pubitemid 38967569)
25. Möller M., de Wit E., Hoal E. G., Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunology and Medical Microbiology 2010 58 1 3 26 2-s2.0-74549167799 10.1111/j.1574-695X.2009. 00600.x
26. Portevin D., Gagneux S., Comas I., Young D., Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathogens 2011 7 3 2-s2.0-79953274965 10.1371/journal.ppat.1001307 e1001307
27. Wang C., Peyron P., Mestre O., Kaplan G., van Soolingen D., Gao Q., Gicquel B., Neyrolles O., Innate immune response to mycobacterium tuberculosis Beijing and other genotypes. PLoS One 2010 5 10 2-s2.0-78149417911 10.1371/journal.pone.0013594 e13594
28. Krishnan N., Malaga W., Constant P., Caws M., Thi Hoang Chau T., Salmons J., Thi Ngoc Lan N., Bang N. D., Daffé M., Young D. B., Robertson B. D., Guilhot C., Thwaites G. E., Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles. PLoS One 2011 6 9 2-s2.0-80052530215 10.1371/journal.pone. 0023870 e23870
29. Sarkar R., Lenders L., Wilkinson K. A., Wilkinson R. J., Nicol M. P., Modern lineages of Mycobacterium tuberculosis exhibit lineage-specific patterns of growth and cytokine induction in human monocyte-derived macrophages. PloS One 2012 7 8 e43170
30. Carmona J., Cruz A., Moreira-Teixeira L., Sousa C., Strains are differentially recognized by TLRs with an impact on the immune response. PloS One 2013 8 6 e67277
31. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 2006 124 4 783 801 2-s2.0-32944464648 10.1016/j.cell.2006.02.015 (Pubitemid 43261452)
32. Jo E.-K., Mycobacterial interaction with innate receptors: TLRs, C-type lectins, and NLRs. Current Opinion in Infectious Diseases 2008 21 3 279 286 2-s2.0-42949134356 10.1097/QCO.0b013e3282f88b5d (Pubitemid 351620382)
33. Harding C. V., Boom W. H., Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nature Reviews Microbiology 2010 8 4 296 307 2-s2.0-77949550080 10.1038/nrmicro2321
34. El-Etr S. H., Cirillo J. D., Entry mechanisms of mycobacteria. Frontiers in Bioscience 2001 6 D737 D747 2-s2.0-0035380710
35. Sandor F., Buc M., Toll-like receptors. I. Structure, function and their ligands. Folia Biologica 2005 51 5 148 157 2-s2.0-27844604955 (Pubitemid 41645216)
36. Underhill D. M., Ozinsky A., Smith K. D., Aderem A., Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proceedings of the National Academy of Sciences of the United States of America 1999 96 25 14459 14463 2-s2.0-0033458799 10.1073/pnas.96.25.14459 (Pubitemid 30000672)
37. Takeda K., Akira S., TLR signaling pathways. Seminars in Immunology 2004 16 1 3 9 2-s2.0-0742324860 10.1016/j.smim.2003.10.003 (Pubitemid 38147427)
38. Akira S., Toll-like receptor signaling. Journal of Biological Chemistry 2003 278 40 38105 38108 2-s2.0-0141532262 10.1074/jbc.R300028200 (Pubitemid 37221695)
39. Quesniaux V., Fremond C., Jacobs M., Parida S., Nicolle D., Yeremeev V., Bihl F., Erard F., Botha T., Drennan M., Soler M.-N., Le Bert M., Schnyder B., Ryffel B., Toll-like receptor pathways in the immune responses to mycobacteria. Microbes and Infection 2004 6 10 946 959 2-s2.0-4043171986 10.1016/j.micinf. 2004.04.016 (Pubitemid 39061217)
40. Ryffel B., Fremond C., Jacobs M., Parida S., Botha T., Schnyder B., Quesniaux V., Innate immunity to mycobacterial infection in mice: critical role for toll-like receptors. Tuberculosis 2005 85 5-6 395 405 2-s2.0-27744448143 10.1016/j.tube.2005.08.021 (Pubitemid 41617394)
41. Reiling N., Ehlers S., Hölscher C., MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. Immunology Letters 2008 116 1 15 23 2-s2.0-38549174086 10.1016/j.imlet.2007.11.015
42. Bafica A., Feng C. G., Santiago H. C., Aliberti J., Cheever A., Thomas K. E., Taylor G. A., Vogel S. N., Sher A., The IFN-inducible GTPase LRG47 (Irgm1) negatively regulates TLR4-triggered proinflammatory cytokine production and prevents endotoxemia. Journal of Immunology 2007 179 8 5514 5522 2-s2.0-38449097465
43. Brightbill H. D., Libraty D. H., Krutzik S. R., Yang R.-B., Belisle J. T., Bleharski J. R., Maitland M., Norgard M. V., Plevy S. E., Smale S. T., Brennan P. J., Bloom B. R., Godowski P. J., Modlin R. L., Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 1999 285 5428 732 736 2-s2.0-0033618562 10.1126/science.285.5428.732 (Pubitemid 29484541)
44. Pecora N. D., Gehring A. J., Canaday D. H., Boom W. H., Harding C. V., Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function. Journal of Immunology 2006 177 1 422 429 2-s2.0-33745298718 (Pubitemid 43939154)
45. Gehring A. J., Dobos K. M., Belisle J. T., Harding C. V., Boom W. H., Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing. Journal of Immunology 2004 173 4 2660 2668 2-s2.0-4043072746 (Pubitemid 39063126)
46. Quesniaux V. J., Nicolle D. M., Torres D., Kremer L., Guérardel Y., Nigou J., Puzo G., Erard F., Ryffel B., Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. Journal of Immunology 2004 172 7 4425 4434 2-s2.0-1642375617 (Pubitemid 38375258)
47. Gilleron M., Himoudi N., Adam O., Constant P., Venisse A., Rivière M., Puzo G., Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans: structure and localization of alkali-labile and alkali-stable phosphoinositides. Journal of Biological Chemistry 1997 272 1 117 124 2-s2.0-0031023165 10.1074/jbc.272.1.117 (Pubitemid 27021133)
48. Jones B. W., Means T. K., Heldwein K. A., Keen M. A., Hill P. J., Belisle J. T., Fenton M. J., Different Toll-like receptor agonists induce distinct macrophage responses. Journal of Leukocyte Biology 2001 69 6 1036 1044 2-s2.0-0034976848 (Pubitemid 32577908)
49. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M. T., Engele M., Sieling P. A., Barnes P. F., Röllinghoff M., Bölcskei P. L., Wagner M., Akira S., Norgard M. V., Belisle J. T., Godowski P. J., Bloom B. R., Modlin R. L., Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001 291 5508 1544 1547 2-s2.0-0035936836 10.1126/science.291.5508.1544 (Pubitemid 32179220)
50. Drennan M. B., Nicolle D., Quesniaux V. J. F., Jacobs M., Allie N., Mpagi J., Frémond C., Wagner H., Kirschning C., Ryffel B., Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. American Journal of Pathology 2004 164 1 49 57 2-s2.0-1542574298 (Pubitemid 38364589)
51. Reiling N., Hölscher C., Fehrenbach A., Kröger S., Kirschning C. J., Goyert S., Ehlers S., Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. Journal of Immunology 2002 169 7 3480 3484 2-s2.0-0036784614
52. Liu P. T., Stenger S., Li H., Wenzel L., Tan B. H., Krutzik S. R., Ochoa M. T., Schauber J., Wu K., Meinken C., Kamen D. L., Wagner M., Bals R., Steinmeyer A., Zügel U., Gallo R. L., Eisanberg D., Hewison M., Hollis B. W., Adams J. S., Bloom B. R., Modlin R. L., Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006 311 5768 1770 1773 2-s2.0-33645224419 10.1126/science.1123933
53. Ogus A. C., Yoldas B., Ozdemir T., Uguz A., Olcen S., Kaser I., Coskun M., Cilli A., Yegin O., The Arg753Gln polymorphism of the human Toll-like receptor 2 gene in tuberculosis disease. European Respiratory Journal 2004 23 2 219 223 2-s2.0-1042269515 10.1183/09031936.03.00061703 (Pubitemid 38195506)
54. Ben-Ali M., Barbouche M.-R., Bousnina S., Chabbou A., Dellagi K., Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clinical and Diagnostic Laboratory Immunology 2004 11 3 625 626 2-s2.0-2442714055 10.1128/CDLI.11.3.625-626.2004 (Pubitemid 38661434)
55. Caws M., Thwaites G., Dunstan S., Hawn T. R., Lan N. T. N., Thuong N. T. T., Stepniewska K., Huyen M. N. T., Nguyen D. B., Tran H. L., Gagneux S., van Soolingen D., Kremer K., van der Sande M., Small P., Anh P. T. H., Nguyen T. C., Hoang T. Q., Duyen N. T. H., Dau Q. T., Hieu N. T., Torok E., Tran T. H., Nguyen H. D., Nhu N. T. Q., Phan M. D., Chau N. V. V., Farrar J., The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathogens 2008 4 3 2-s2.0-42949174158 10.1371/journal.ppat.1000034 e1000034 (Pubitemid 351631085)
56. Thuong N. T. T., Hawn T. R., Thwaites G. E., Chau T. T. H., Lan N. T. N., Quy H. T., Hieu N. T., Aderem A., Hien T. T., Farrar J. J., Dunstan S. J., A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes and Immunity 2007 8 5 422 428 2-s2.0-34547409225 10.1038/sj.gene.6364405 (Pubitemid 47163105)
57. Akira S., Takeda K., Kaisho T., Toll-like receptors: critical proteins linking innate and acquired immunity. Nature Immunology 2001 2 8 675 680 2-s2.0-0034886143 10.1038/90609 (Pubitemid 32747155)
58. Bulut Y., Michelsen K. S., Hayrapetian L., Naiki Y., Spallek R., Singh M., Arditi M., Mycobacterium tuberculosis heat shock proteins use diverse toll-like receptor pathways to activate pro-inflammatory signals. Journal of Biological Chemistry 2005 280 22 20961 20967 2-s2.0-20444387233 10.1074/jbc.M411379200 (Pubitemid 40805653)
59. Cehovin A., Coates A. R. M., Hu Y., Riffo-Vasquez Y., Tormay P., Botanch C., Altare F., Henderson B., Comparison of the moonlighting actions of the two highly homologous chaperonin 60 proteins of Mycobacterium tuberculosis. Infection and Immunity 2010 78 7 3196 3206 2-s2.0-77953952682 10.1128/IAI.01379-09
60. Kim K., Sohn H., Kim J.-S., Choi H.-G., Byun E.-H., Lee K.-I., Shin S. J., Song C.-H., Park J.-K., Kim H.-J., Mycobacterium tuberculosis Rv0652 stimulates production of tumour necrosis factor and monocytes chemoattractant protein-1 in macrophages through the Toll-like receptor 4 pathway. Immunology 2012 136 2 231 240 2-s2.0-84860231061 10.1111/j.1365-2567.2012.03575.x
61. Jung S.-B., Yang C.-S., Lee J.-S., Shin A.-R., Jung S.-S., Son J. W., Harding C. V., Kim H.-J., Park J.-K., Paik T.-H., Song C.-H., Jo E.-K., The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes. Infection and Immunity 2006 74 5 2686 2696 2-s2.0-33646357881 10.1128/IAI.74.5.2686-2696.2006 (Pubitemid 43672977)
62. Means T. K., Jones B. W., Schromm A. B., Shurtleff B. A., Smith J. A., Keane J., Golenbock D. T., Vogel S. N., Fenton M. J., Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. Journal of Immunology 2001 166 6 4074 4082 2-s2.0-0035869553 (Pubitemid 32224938)
63. Branger J., Leemans J. C., Florquin S., Weijer S., Speelman P., van der Poll T., Toll-like receptor 4 plays a protective role in pulmonary tuberculosis in mice. International Immunology 2004 16 3 509 516 2-s2.0-1542329600 10.1093/intimm/dxh052 (Pubitemid 38313159)
64. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S., A Toll-like receptor recognizes bacterial DNA. Nature 2000 408 6813 740 745 2-s2.0-0034619794 10.1038/35047123 (Pubitemid 32015992)
65. Bafica A., Scanga C. A., Feng C. G., Leifer C., Cheever A., Sher A., TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. The Journal of Experimental Medicine 2005 202 12 1715 1724 2-s2.0-29144434113 10.1084/jem.20051782 (Pubitemid 41815877)
66. Hickman S. P., Chan J., Salgame P., Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with divergent effects on naive T cell polarization. Journal of Immunology 2002 168 9 4636 4642 2-s2.0-0036569397 (Pubitemid 34441370)
67. Jang S., Uematsu S., Akira S., Salgame P., IL-6 and IL-10 induction from dendritic cells in response to mycobacterium tuberculosis is predominantly dependent on TLR2-mediated recognition. Journal of Immunology 2004 173 5 3392 3397 2-s2.0-4344575766 (Pubitemid 39142049)
68. Uehori J., Fukase K., Akazawa T., Uematsu S., Akira S., Funami K., Shingai M., Matsumoto M., Azuma I., Toyoshima K., Kusumoto S., Seya T., Dendritic cell maturation induced by muramyl dipeptide (MDP) derivatives: monoacylated MDP confers TLR2/TLR4 activation. Journal of Immunology 2005 174 11 7096 7103 2-s2.0-21044457217 (Pubitemid 40705675)
69. Ferguson J. S., Weis J. J., Martin J. L., Schlesinger L. S., Complement protein C3 binding to Mycobacterium tuberculosis is initiated by the classical pathway in human bronchoalveolar lavage fluid. Infection and Immunity 2004 72 5 2564 2573 2-s2.0-2142698651 10.1128/IAI.72.5.2564-2573.2004 (Pubitemid 38542382)
70. Schlesinger L. S., Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. Journal of Immunology 1993 150 7 2920 2930 2-s2.0-0027173039 (Pubitemid 23127541)
71. Schlesinger L. S., Bellinger-Kawahara C. G., Payne N. R., Horwitz M. A., Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. Journal of Immunology 1990 144 7 2771 2780 2-s2.0-0025216480 (Pubitemid 20136689)
72. Sturgill-Koszycki S., Haddix P. L., Russell D. G., The interaction between Mycobacterium and the macrophage analyzed by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 1997 18 14 2558 2565 2-s2.0-0031408448 10.1002/elps.1150181411 (Pubitemid 28133337)
73. Schlesinger L. S., Kaufman T. M., Iyer S., Hull S. R., Marchiando L. K., Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages. Journal of Immunology 1996 157 10 4568 4575 2-s2.0-0030588707 (Pubitemid 126449378)
74. Kang P. B., Azad A. K., Torrelles J. B., Kaufman T. M., Beharka A., Tibesar E., DesJardin L. E., Schlesinger L. S., The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis. The Journal of Experimental Medicine 2005 202 7 987 999 2-s2.0-25844508945 10.1084/jem.20051239 (Pubitemid 41396898)
75. Sweet L., Singh P. P., Azad A. K., Rajaram M. V. S., Schlesinger L. S., Schorey J. S., Mannose receptor-dependent delay in phagosome maturation by Mycobacterium avium glycopeptidolipids. Infection and Immunity 2010 78 1 518 526 2-s2.0-73449101489 10.1128/IAI.00257-09
76. Divangahi M., Mostowy S., Coulombe F., Kozak R., Guillot L., Veyrier F., Kobayashi K. S., Flavell R. A., Gros P., Behr M. A., NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. Journal of Immunology 2008 181 10 7157 7165 2-s2.0-58149189054
77. Ferwerda G., Girardin S. E., Kullberg B.-J., le Bourhis L., de Jong D. J., Langenberg D. M. L., van Crevel R., Adema G. J., Ottenhoff T. H. M., van der Meer J. W. M., Netea M. G., NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathogens 2005 1 3 279 285 2-s2.0-77951073629 10.1371/journal.ppat.0010034
78. Yang Y., Yin C., Pandey A., Abbott D., Sassetti C., Kelliher M. A., NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. Journal of Biological Chemistry 2007 282 50 36223 36229 2-s2.0-37548999003 10.1074/jbc.M703079200
79. Pandey A. K., Yang Y., Jiang Z., Fortune S. M., Coulombe F., Behr M. A., Fitzgerald K. A., Sassetti C. M., Kelliher M. A., Nod2, Rip2 and Irf5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathogens 2009 5 7 2-s2.0-70049094025 10.1371/journal.ppat.1000500 e1000500
80. Shams H., Wizel B., Lakey D. L., Samten B., Vankayalapati R., Valdivia R. H., Kitchens R. L., Griffith D. E., Barnes P. F., The CD14 receptor does not mediate entry of Mycobacterium tuberculosis into human mononuclear phagocytes. FEMS Immunology and Medical Microbiology 2003 36 1-2 63 69 2-s2.0-0037448086 10.1016/S0928-8244(03)00039-7 (Pubitemid 36515085)
81. Khanna M., Srivastava L. M., Release of superoxide anion from activated mouse peritoneal macrophages during Mycobacterium tuberculosis infection. Indian Journal of Experimental Biology 1996 34 5 468 471 2-s2.0-0030133619 (Pubitemid 126509273)
82. Dinadayala P., Lemassu A., Granovski P., Cérantola S., Winter N., Daffé M., Revisiting the structure of the anti-neoplastic glucans of Mycobacterium bovis Bacille Calmette-Guérin: structural analysis of the extracellular and boiling water extract-derived glucans of the vaccine substrains. Journal of Biological Chemistry 2004 279 13 12369 12378 2-s2.0-1842582661 10.1074/jbc.M308908200 (Pubitemid 38445804)
83. van de Veerdonk F. L., Teirlinck A. C., Kleinnijenhuis J., Kullberg B. J., van Crevel R., van der Meer J. W. M., Joosten L. A. B., Netea M. G., Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. Journal of Leukocyte Biology 2010 88 2 227 232 2-s2.0-77956399376 10.1189/jlb.0809550
84. Rothfuchs A. G., Bafica A., Feng C. G., Egen J. G., Williams D. L., Brown G. D., Sher A., Dectin-1 interaction with Mycobacterium tuberculosis leads to enhanced IL-12p40 production by splenic dendritic cells. Journal of Immunology 2007 179 6 3463 3471 2-s2.0-35748951920
85. Yadav M., Schorey J. S., The β -glucan receptor dectin-1 functions together with TLR2 to mediate macrophage activation by mycobacteria. Blood 2006 108 9 3168 3175 2-s2.0-33751176262 10.1182/blood-2006-05-024406
86. Marakalala M. J., Guler R., Matika L., Murray G., Jacobs M., Brombacher F., Rothfuchs A. G., Sher A., Brown G. D., The Syk/CARD9-coupled receptor Dectin-1 is not required for host resistance to Mycobacterium tuberculosis in mice. Microbes and Infection 2011 13 2 198 201 2-s2.0-78651501496 10.1016/j.micinf.2010.10.013
87. Dorhoi A., Desel C., Yeremeev V., Pradl L., Brinkmann V., Mollenkopf H.-J., Hanke K., Gross O., Ruland J., Kaufmann S. H. E., The adaptor molecule CARD9 is essential for tuberculosis control. The Journal of Experimental Medicine 2010 207 4 777 792 2-s2.0-77951037591 10.1084/jem.20090067
88. Marakalala M. J., Graham L. M., Brown G. D., The role of Syk/CARD9-coupled C-type lectin receptors in immunity to mycobacterium tuberculosis infections. Clinical and Developmental Immunology 2010 2010 9 2-s2.0-79952206848 10.1155/2010/567571 567571
89. Zimmerli S., Edwards S., Ernst J. D., Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. American Journal of Respiratory Cell and Molecular Biology 1996 15 6 760 770 2-s2.0-0030331770 (Pubitemid 126441449)
90. Armstrong J. A., D'Arcy Hart P., Phagosome lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. The Journal of Experimental Medicine 1975 142 1 1 16 2-s2.0-0016742008
91. Geijtenbeek T. B. H., Torensma R., van Vliet S. J., van Duijnhoven G. C. F., Adema G. J., van Kooyk Y., Figdor C. G., Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000 100 5 575 585 2-s2.0-0034598934
92. Geijtenbeek T. B. H., Krooshoop D. J. E. B., Bleijs D. A., van Vliet S. J., van Duijnhoven G. C. F., Grabovsky V., Alon R., Figdor C. G., van Kooyk Y., DC-SIGN-1CAM-2 interaction mediates dendritic cell trafficking. Nature Immunology 2000 1 4 353 357 2-s2.0-0034304945
93. Geijtenbeek T., van Vliet S. J., Koppel E. A., Sanchez-Hernandez M., Vandenbroucke-Grauls C. M. J. E., Appelmelk B., van Kooyk Y., Mycobacteria target DC-SIGN to suppress dendritic cell function. The Journal of Experimental Medicine 2003 197 1 7 17 2-s2.0-0037237593 10.1084/jem.20021229 (Pubitemid 36110253)
94. Tanne A., Ma B., Boudou F., Tailleux L., Botella H., Badell E., Levillain F., Taylor M. E., Drickamer K., Nigou J., Dobos K. M., Puzo G., Vestweber D., Wild M. K., Marcinko M., Sobieszczuk P., Stewart L., Lebus D., Gicquel B., Neyrolles O., A murine DC-SIGN homologue contributes to early host defense against Mycobacterium tuberculosis. The Journal of Experimental Medicine 2009 206 10 2205 2220 2-s2.0-70350459593 10.1084/jem.20090188
95. Tanne A., Neyrolles O., C-type lectins in immune defense against pathogens the murine DC-SIGN homologue SIGNR3 confers early protection against mycobacterium tuberculosis infection. Virulence 2010 1 4 285 290 2-s2.0-77955048144
96. Barreiro L. B., Neyrolles O., Babb C. L., Tailleux L., Quach H., McElreavey K., van Helden P. D., Hoal E. G., Gicquel B., Quintana-Murci L., Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Medicine 2006 3 2, article e20 2-s2.0-33644836015 10.1371/journal.pmed.0030020 (Pubitemid 43362876)
97. Barreiro L. B., Quach H., Krahenbuhl J., Khaliq S., Mohyuddin A., Mehdi S. Q., Gicquel B., Neyrolles O., Quintana-Murci L., DC-SIGN interacts with mycobacterium ieprae but sequence variation in this lectin is not associated with leprosy in the Pakistani population. Human Immunology 2006 67 1-2 102 107 2-s2.0-33646368405 10.1016/j.humimm.2006.02.028 (Pubitemid 43673917)
98. Barreiro L. B., Neyrolles O., Babb C. L., van Helden P. D., Gicquel B., Hoal E. G., Quintana-Murci L., Length variation of DC-SIGN and L-SIGN neck-region has no impact on tuberculosis susceptibility. Human Immunology 2007 68 2 106 112 2-s2.0-33847143776 10.1016/j.humimm.2006.10.020 (Pubitemid 46282214)
99. Gaynor C. D., McCormack F. X., Voelker D. R., McGowan S. E., Schlesinger L. S., Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. Journal of Immunology 1995 155 11 5343 5351 2-s2.0-0028832349
100. Downing J. F., Pasula R., Wright J. R., Twigg H. L. III, Martin W. J. II, Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proceedings of the National Academy of Sciences of the United States of America 1995 92 11 4848 4852 2-s2.0-0029035691 10.1073/pnas.92.11.4848
101. Pasula R., Wright J. R., Kachel D. L., Martin W. J. II, Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. The Journal of Clinical Investigation 1999 103 4 483 490 2-s2.0-0033557301 (Pubitemid 29094048)
102. Stenger S., Immunological control of tuberculosis: role of tumour necrosis factor and more. Annals of the Rheumatic Diseases 2005 64 supplement 4 iv24 iv28 2-s2.0-27444432605 10.1136/ard.2005.042531 (Pubitemid 41532012)
103. Mohan V. P., Scanga C. A., Yu K., Scott H. M., Tanaka K. E., Tsang E., Tsai M. C., Flynn J. L., Chan J., Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infection and Immunity 2001 69 3 1847 1855 2-s2.0-0035118698 10.1128/IAI.69.3.1847-1855.2001 (Pubitemid 32187645)
104. Casarini M., Ameglio F., Alemanno L., Zangrilli P., Mattia P., Paone G., Bisetti A., Giosuè S., Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine 1999 159 1 143 148 2-s2.0-0032932501 (Pubitemid 29036517)
105. Kaneko H., Yamada H., Mizuno S., Udagawa T., Kazumi Y., Sekikawa K., Sugawara I., Role of tumor necrosis factor- α in Mycobacterium-induced granuloma formation in tumor necrosis factor- α -deficient mice. Laboratory Investigation 1999 79 4 379 386 2-s2.0-0032956593 (Pubitemid 29190427)
106. Senaldi G., Yin S., Shaklee C. L., Piguet P.-F., Mak T. W., Ulich T. R., Corynebacterium parvum- and mycobacterium bovis bacillus calmette-Guérin- induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI. Journal of Immunology 1996 157 11 5022 5026 2-s2.0-0030459359 (Pubitemid 126449582)
107. Kindler V., Sappino A.-P., Grau G. E., Piguet P.-F., Vassalli P., The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989 56 5 731 740 2-s2.0-0024566140 (Pubitemid 19082507)
108. Flynn J. L., Goldstein M. M., Chan J., Triebold K. J., Pfeffer K., Lowenstein C. J., Schreiber R., Mak T. W., Bloom B. R., Tumor necrosis factor- α is required in the protective immune response against mycobacterium tuberculosis in mice. Immunity 1995 2 6 561 572 2-s2.0-0028979703
109. Chan J., Xing Y., Magliozzo R. S., Bloom B. R., Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. The Journal of Experimental Medicine 1992 175 4 1111 1122 2-s2.0-0026549480
110. Keane J., Balcewicz-Sablinska M. K., Remold H. G., Chupp G. L., Meek B. B., Fenton M. J., Kornfeld H., Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infection and Immunity 1997 65 1 298 304 2-s2.0-0031015731 (Pubitemid 27008937)
111. Saunders B. M., Britton W. J., Life and death in the granuloma: immunopathology of tuberculosis. Immunology and Cell Biology 2007 85 2 103 111 2-s2.0-33947172058 10.1038/sj.icb.7100027 (Pubitemid 46398725)
112. Clay H., Volkman H. E., Ramakrishnan L., Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 2008 29 2 283 294 2-s2.0-48749114458 10.1016/j.immuni.2008.06.011
113. Gardam M. A., Keystone E. C., Menzies R., Manners S., Skamene E., Long R., Vinh D. C., Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infectious Diseases 2003 3 3 148 155 2-s2.0-0037373957 10.1016/S1473-3099(03)00545-0 (Pubitemid 36278124)
114. van Crevel R., van der Ven-Jongekrijg J., Netea M. G., de Lange W., Kullberg B.-J., van der Meer J. W. M., Disease, specific ex vivo stimulation of whole blood for cytokine production: applications in the study of tuberculosis. Journal of Immunological Methods 1999 222 1-2 145 153 2-s2.0-0032923520 10.1016/S0022-1759(98)00192-6 (Pubitemid 29023711)
115. Flesch I., Kaufmann S. H. E., Mycobacterial growth inhibition by interferon- γ -activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. Journal of Immunology 1987 138 12 4408 4413 2-s2.0-0023228483 (Pubitemid 17096447)
116. Cooper A. M., Dalton D. K., Stewart T. A., Griffin J. P., Russell D. G., Orme I. M., Disseminated tuberculosis in interferon γ gene-disrupted mice. The Journal of Experimental Medicine 1993 178 6 2243 2247 2-s2.0-0027482327 10.1084/jem.178.6.2243 (Pubitemid 23344885)
117. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J.-F., Newport M., Levin M., Blanche S., Seboun E., Fischer A., Casanova J.-L., Interferon- γ -receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. The New England Journal of Medicine 1996 335 26 1956 1961 2-s2.0-0030455878
118. Zhang M., Lin Y., Iyer D. V., Gong J., Abrams J. S., Barnes P. F., T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infection and Immunity 1995 63 8 3231 3234 2-s2.0-0029134099
119. Ting L.-M., Kim A. C., Cattamanchi A., Ernst J. D., Mycobacterium tuberculosis inhibits IFN- γ transcriptional responses without inhibiting activation of STAT1. Journal of Immunology 1999 163 7 3898 3906 2-s2.0-0033214553 (Pubitemid 29450917)
120. Munder M., Mallo M., Eichmann K., Modolell M., Direct stimulation of macrophages by IL-12 and IL-18-a bridge built on solid ground. Immunology
121. Munder M., Mallo M., Eichmann K., Modolell M., Murine macrophages secrete interferon γ upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. The Journal of Experimental Medicine 1998 187 12 2103 2108 2-s2.0-0032526840 10.1084/jem.187.12.2103 (Pubitemid 28285581)
122. Salazar-Mather T. P., Hamilton T. A., Biron C. A., A chemokine-to- cytokine-to-chemokine cascade critical in antiviral defense. The Journal of Clinical Investigation 2000 105 7 985 993 2-s2.0-0034045085 (Pubitemid 30203071)
123. Pien G. C., Satoskar A. R., Takeda K., Akira S., Biron C. A., Cutting edge: selective IL-18 requirements for induction of compartmental IFN- γ responses during viral infection. Journal of Immunology 2000 165 9 4787 4791 2-s2.0-0034327172
124. Ladel C. H., Szalay G., Riedel D., Kaufmann S. H. E., Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages. Infection and Immunity 1997 65 5 1936 1938 2-s2.0-0030981997 (Pubitemid 27193622)
125. Flynn J. L., Goldstein M. M., Triebold K. J., Sypek J., Wolf S., Bloom B. R., IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. Journal of Immunology 1995 155 5 2515 2524 2-s2.0-0029078676
126. Zhang M., Gately M. K., Wang E., Gong J., Wolf S. F., Lu S., Modlin R. L., Barnes P. F., Interleukin 12 at the site of disease in tuberculosis. The Journal of Clinical Investigation 1994 93 4 1733 1739 2-s2.0-0028220266 (Pubitemid 24116415)
127. Bergeron A., Bonay M., Kambouchner M., Lecossier D., Riquet M., Soler P., Hance A., Tazi A., Cytokine patterns in tuberculous and sarcoid granulomas: correlations with histopathologic features of the granulomatous response. Journal of Immunology 1997 159 6 3034 3043 2-s2.0-0031571868 (Pubitemid 127681328)
128. Zhang M., Gong J., Presky D. H., Xue W., Barnes P. F., Expression of the IL-12 receptor β 1 and β 2 subunits in human tuberculosis. Journal of Immunology 1999 162 4 2441 2447 2-s2.0-0033558107 (Pubitemid 29288874)
129. Altare F., Ensser A., Breiman A., Reichenbach J., El Baghdadi J., Fischer A., Emile J.-F., Gaillard J.-L., Meinl E., Casanova J.-L., Interleukin-12 receptor β 1 deficiency in a patient with abdominal tuberculosis. Journal of Infectious Diseases 2001 184 2 231 236 2-s2.0-0035879825 10.1086/321999 (Pubitemid 32614057)
130. Altare F., Lammas D., Revy P., Jouanguy E., Döffinger R., Lamhamedi S., Drysdale P., Scheel-Toeilner D., Girdlestone J., Darbyshire P., Wadhwa M., Dockrell H., Salmon M., Fischer A., Durandy A., Casanova J.-L., Kumararatne D. S., Inherited interleukin 12 deficiency in a child with bacille Calmette- Guerin and Salmonella enteritidis disseminated infection. The Journal of Clinical Investigation 1998 102 12 2035 2040 2-s2.0-0032535370 (Pubitemid 29018809)
131. Altare F., Durandy A., Lammas D., Emile J.-F., Lamhamedi S., Le Deist F., Drysdale P., Jouanguy E., Döffinger R., Bernaudin F., Jeppsson O., Gollob J. A., Meinl E., Segal A. W., Fischer A., Kumararatne D., Casanova J.-L., Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998 280 5368 1432 1435 2-s2.0-18244428735 10.1126/science.280.5368.1432 (Pubitemid 28264836)
132. Cooper A. M., Magram J., Ferrante J., Orme I. M., Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. The Journal of Experimental Medicine 1997 186 1 39 45 2-s2.0-0030790652 10.1084/jem.186.1.39 (Pubitemid 27304845)
133. Netea M. G., Kullberg B. J., Verschueren I., van der Meer J. W., Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. European Journal of Immunology 2000 30 10 3057 3060
134. Sugawara I., Yamada H., Kaneko H., Mizuno S., Takeda K., Akira S., Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18- gene-disrupted mice. Infection and Immunity 1999 67 5 2585 2589 2-s2.0-0032924518 (Pubitemid 29200522)
135. Kobayashi K., Kai M., Gidoh M.-I., Nakata N., Endoh M., Singh R. P., Kasama T., Saito H., The possible role of interleukin (IL)-12 and interferon- γ -inducing factor/IL-18 in protection against experimental Mycobacterium leprae infection in mice. Clinical Immunology and Immunopathology 1998 88 3 226 231 2-s2.0-0032169916 10.1006/clin.1998.4533 (Pubitemid 28436243)
136. Vankayalapati R., Wizel B., Weis S. E., Samten B., Girard W. M., Barnes P. F., Production of interleukin-18 in human tuberculosis. Journal of Infectious Diseases 2000 182 1 234 239 2-s2.0-0033930337 10.1086/315656 (Pubitemid 30497809)
137. Law K., Weiden M., Harkin T., Tchou-Wong K., Chi C., Rom W. N., Increased release of interleukin-1 β interleukin-6, and tumor necrosis factor- α by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine 1996 153 2 799 804 2-s2.0-0029670952
138. Juffermans N. P., Florquin S., Camoglio L., Verbon A., Kolk A. H., Speelman P., van Deventer S. J. H., van der Poll T., Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. Journal of Infectious Diseases 2000 182 3 902 908 2-s2.0-0033823682 10.1086/315771
139. Yamada H., Mizumo S., Horai R., Iwakura Y., Sugawara I., Protective role of interleukin-1 in mycobacterial infection in IL-1 α / β double-knockout mice. Laboratory Investigation 2000 80 5 759 767 2-s2.0-0034087034 (Pubitemid 30340660)
140. Sugawara I., Yamada H., Hua S., Mizuno S., Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection. Microbiology and Immunology 2001 45 11 743 750 2-s2.0-0035196862 (Pubitemid 33111351)
141. Fremond C. M., Yeremeev V., Nicolle D. M., Jacobs M., Quesniaux V. F., Ryffel B., Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. The Journal of Clinical Investigation 2004 114 12 1790 1799 2-s2.0-14044253038 10.1172/JCI200421027 (Pubitemid 40385535)
142. Scanga C. A., Bafica A., Feng C. G., Cheever A. W., Hieny S., Sher A., MyD88-deficient mice display a profound loss in resistance to Mycobacterium tuberculosis associated with partially impaired Th1 cytokine and nitric oxide synthase 2 expression. Infection and Immunity 2004 72 4 2400 2404 2-s2.0-1842588021 10.1128/IAI.72.4.2400-2404.2004 (Pubitemid 38419959)
143. Hölscher C., Reiling N., Schaible U. E., Hölscher A., Bathmann C., Korbel D., Lenz I., Sonntag T., Kröger S., Akira S., Mossmann H., Kirschning C. J., Wagner H., Freudenberg M., Ehlers S., Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9. European Journal of Immunology 2008 38 3 680 694 2-s2.0-43649084921 10.1002/eji.200736458
144. Mayer-Barber K. D., Barber D. L., Shenderov K., White S. D., Wilson M. S., Cheever A., Kugler D., Hieny S., Caspar P., Núñez G., Schlueter D., Flavell R. A., Sutterwala F. S., Sher A., Cutting edge: caspase-1 independent IL-1 β production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo. Journal of Immunology 2010 184 7 3326 3330 2-s2.0-77951628300 10.4049/jimmunol.0904189
145. Fremond C. M., Togbe D., Doz E., Rose S., Vasseur V., Maillet I., Jacobs M., Ryffel B., Quesniaux V. F. J., IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. Journal of Immunology 2007 179 2 1178 1189 2-s2.0-34548704962
146. Saunders B. M., Frank A. A., Orme I. M., Cooper A. M., Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infection and Immunity 2000 68 6 3322 3326 2-s2.0-0034035311 10.1128/IAI.68.6.3322-3326.2000 (Pubitemid 30340426)
147. Schindler R., Mancilla J., Endres S., Ghorbani R., Clark S. C., Dinarello C. A., Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990 75 1 40 47 2-s2.0-0025176658 (Pubitemid 20031487)
148. Wiekowski M. T., Leach M. W., Evans E. W., Sullivan L., Chen S.-C., Vassileva G., Bazan J. F., Gorman D. M., Kastelein R. A., Narula S., Lira S. A., Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. Journal of Immunology 2001 166 12 7563 7570 2-s2.0-0035877257 (Pubitemid 32525637)
149. Cooper A. M., Roberts A. D., Rhoades E. R., Callahan J. E., Getzy D. M., Orme I. M., The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 1995 84 3 423 432 2-s2.0-0028947010
150. Cooper A. M., Kipnis A., Turner J., Magram J., Ferrante J., Orme I. M., Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. Journal of Immunology 2002 168 3 1322 1327 2-s2.0-0036467445 (Pubitemid 34094502)
151. Khader S. A., Pearl J. E., Sakamoto K., Gilmartin L., Bell G. K., Jelley-Gibbs D. M., Ghilardi N., DeSauvage F., Cooper A. M., IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN- γ responses if IL-12p70 is available. Journal of Immunology 2005 175 2 788 795 2-s2.0-23244458100 (Pubitemid 41094960)
152. Khader S. A., Guglani L., Rangel-Moreno J., Gopal R., Fallert Junecko B. A., Fountain J. J., Martino C., Pearl J. E., Tighe M., Lin Y.-Y., Slight S., Kolls J. K., Reinhart T. A., Randall T. D., Cooper A. M., IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. Journal of Immunology 2011 187 10 5402 5407 2-s2.0-81455131790 10.4049/jimmunol.1101377
153. Wozniak T. M., Ryan A. A., Triccas J. A., Britton W. J., Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infection and Immunity 2006 74 1 557 565 2-s2.0-29644444042 10.1128/IAI.74.1.557-565.2006 (Pubitemid 43023111)
154. Wozniak T. M., Ryan A. A., Britton W. J., Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. Journal of Immunology 2006 177 12 8684 8692 2-s2.0-33845441578 (Pubitemid 44893833)
155. Wozniak T. M., Saunders B. M., Ryan A. A., Britton W. J., Mycobacterium bovis BCG-specific Th17 cells confer partial protection against Mycobacterium tuberculosis infection in the absence of gamma interferon. Infection and Immunity 2010 78 10 4187 4194 2-s2.0-77957735367 10.1128/IAI.01392-09
156. + T cells. American Journal of Respiratory and Critical Care Medicine 2010 181 7 734 742 2-s2.0-77951905021 10.1164/rccm.200909-1463OC
157. + B cell frequencies are increased in patients with tuberculosis and suppress Th17 responses. Cellular Immunology 2012 274 1-2 89 97 2-s2.0-84859926128 10.1016/j.cellimm.2012.01.007
158. Powrie F., Coffman R. L., Inhibition of cell-mediated immunity by IL4 and IL10. Research in Immunology 1993 144 8 639 643 2-s2.0-0027132029 10.1016/S0923-2494(05)80019-7 (Pubitemid 24009462)
159. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 1 23 35 2-s2.0-0037265240 10.1038/nri978 (Pubitemid 37328697)
160. Kahnert A., Seiler P., Stein M., Bandermann S., Hahnke K., Mollenkopf H., Kaufmann S. H. E., Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. European Journal of Immunology 2006 36 3 631 647 2-s2.0-33644940526 10.1002/eji.200535496
161. Essner R., Rhoades K., McBride W. H., Morton D. L., Economou J. S., IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. Journal of Immunology 1989 142 11 3857 3861 2-s2.0-0024408882 (Pubitemid 19164414)
162. Joyce D. A., Steer J. H., IL-4, IL-10 and IFN- γ have distinct, but interacting, effects on differentiation-induced changes in TNF- α and TNF receptor release by cultured human monocytes. Cytokine 1996 8 1 49 57 2-s2.0-0029944865 10.1006/cyto.1996.0007 (Pubitemid 26110937)
163. Rook G. A. W., Th2 cytokines in susceptibility to tuberculosis. Current Molecular Medicine 2007 7 3 327 337 2-s2.0-34248667663 10.2174/ 156652407780598557 (Pubitemid 46767790)
164. Surcel H.-M., Troye-Blomberg M., Paulie S., Andersson G., Moreno C., Pasvol G., Ivanyi J., Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. Immunology 1994 81 2 171 176 2-s2.0-0028240682 (Pubitemid 24223189)
165. Dheda K., Chang J.-S., Breen R. A. M., Haddock J. A., Lipman M. C., Kim L. U., Huggett J. F., Johnson M. A., Rook G. A. W., Zumla A., Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection. AIDS 2005 19 15 1601 1606 2-s2.0-27144516032 (Pubitemid 41502672)
166. Mazzarella G., Bianco A., Perna F., D'Auria D., Grella E., Moscariello E., Sanduzzi A., T lymphocyte phenotypic profile in lung segments affected by cavitary and non-cavitary tuberculosis. Clinical and Experimental Immunology 2003 132 2 283 288 2-s2.0-0037541415 10.1046/j.1365-2249.2003.02121.x (Pubitemid 36560625)
167. Hernández-Pando R., Orozcoe H., Sampieri A., Pavón L., Velasquillo C., Larriva-Sahd J., Alcocer J. M., Madrid M. V., Correlation between the kinetics of Th1/Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996 89 1 26 33 2-s2.0-0029791631 (Pubitemid 26284034)
168. Howard A. D., Zwilling B. S., Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines. Clinical and Experimental Immunology 1999 115 3 428 434 2-s2.0-0032994328 10.1046/j.1365-2249.1999.00791.x (Pubitemid 29130356)
169. + T cells from patients with tuberculosis is related to the presence of pulmonary cavities. Journal of Infectious Diseases 2000 181 3 1194 1197 2-s2.0-0034113481 10.1086/315325 (Pubitemid 30194515)
170. Fujiwara N., Kobayashi K., Macrophages in inflammation. Current Drug Targets 2005 4 3 281 286 2-s2.0-21044449439 10.2174/1568010054022024 (Pubitemid 40873112)
171. Rojas M., Olivier M., Gros P., Barrera L. F., García L. F., TNF- α and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. Journal of Immunology 1999 162 10 6122 6131 2-s2.0-0033563093 (Pubitemid 29314973)
172. Murray P. J., Wang L., Onufryk C., Tepper R. I., Young R. A., T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. Journal of Immunology 1997 158 1 315 321 2-s2.0-0030639088 (Pubitemid 127483871)
173. + T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection. PloS One 2013 8 3 e58612
174. O'Leary S., O'Sullivan M. P., Keane J., IL-10 blocks phagosome maturation in Mycobacterium tuberculosis-infected human macrophages. American Journal of Respiratory Cell and Molecular Biology 2011 45 1 172 180 2-s2.0-80051566116 10.1165/rcmb.2010-0319OC
175. Gazzinelli R. T., Oswald I. P., James S. L., Sher A., IL-10 inhibits parasite killing and nitrogen oxide production by IFN- γ-activated macrophages. Journal of Immunology 1992 148 6 1792 1796 2-s2.0-0026529405
176. Redpath S., Ghazal P., Gascoigne N. R. J., Hijacking and exploitation of IL-10 by intracellular pathogens. Trends in Microbiology 2001 9 2 86 92 2-s2.0-0035252656 10.1016/S0966-842X(00)01919-3 (Pubitemid 32155327)
177. Moore K. W., de Waal Malefyt R., Coffman R. L., O'Garra A., Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 2001 19 683 765 2-s2.0-0035062021 10.1146/annurev.immunol.19.1.683 (Pubitemid 32368050)
178. Khader S. A., Partida-Sanchez S., Bell G., Jelley-Gibbs D. M., Swain S., Pearl J. E., Ghilardi N., DeSauvage F. J., Lund F. E., Cooper A. M., Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection. The Journal of Experimental Medicine 2006 203 7 1805 1815 2-s2.0-33745812070 10.1084/jem.20052545 (Pubitemid 44036285)
179. Redford P. S., Boonstra A., Read S., Pitt J., Graham C., Stavropoulos E., Bancroft G. J., O'Garra A., Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung. European Journal of Immunology 2010 40 8 2200 2210 2-s2.0-77955385939 10.1002/eji.201040433
180. Zhang M., Gong J., Iyer D. V., Jones B. E., Modlin R. L., Barnes P. F., T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. The Journal of Clinical Investigation 1994 94 6 2435 2442 2-s2.0-0028135425 (Pubitemid 24379619)
181. Bonecini-Almeida M. G., Ho J. L., Boéchat N., Huard R. C., Chitale S., Doo H., Geng J., Rego L., Lazzarini L. C. O., Kritski A. L., Johnson W. D. Jr., McCaffrey T. A., Lapa E Silva J. R., Down-modulation of lung immune responses by interleukin-10 and transforming growth factor β (TGF- β) and analysis of TGF- β receptors I and II in active tuberculosis. Infection and Immunity 2004 72 5 2628 2634 2-s2.0-11144358194 10.1128/IAI.72.5.2628-2634. 2004 (Pubitemid 38542389)
182. Huard R. C., Chitale S., Leung M., Lazzarini L. C. O., Zhu H., Shashkina E., Laal S., Conde M. B., Kritski A. L., Belisle J. T., Kreiswirth B. N., Lapa E Silva J. R., Ho J. L., The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10. Infection and Immunity 2003 71 12 6871 6883 2-s2.0-10744228770 10.1128/IAI.71.12.6871-6883. 2003 (Pubitemid 37475317)
183. Turner J., Gonzalez-Juarrero M., Ellis D. L., Basaraba R. J., Kipnis A., Orme I. M., Cooper A. M., In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. Journal of Immunology 2002 169 11 6343 6351 2-s2.0-0036883973 (Pubitemid 36903482)
184. Beamer G. L., Flaherty D. K., Assogba B. D., Stromberg P., Gonzalez-Juarrero M., De Waal Malefyt R., Vesosky B., Turner J., Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice. Journal of Immunology 2008 181 8 5545 5550 2-s2.0-54049132852
185. Roque S., Nobrega C., Appelberg R., Correia-Neves M., IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy. Journal of Immunology 2007 178 12 8028 8035 2-s2.0-34250173749 (Pubitemid 46898074)
186. Jacobs M., Fick L., Allie N., Brown N., Ryffel B., Enhanced immune response in Mycobacterium bovis bacille calmette guerin (BCG)-infected IL-10-deficient mice. Clinical Chemistry and Laboratory Medicine 2002 40 9 893 902 2-s2.0-0036406106 (Pubitemid 35277415)
187. North R. J., Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clinical and Experimental Immunology 1998 113 1 55 58 2-s2.0-0031869869 10.1046/j.1365-2249. 1998.00636.x (Pubitemid 28329065)
188. Higgins D. M., Sanchez-Campillo J., Rosas-Taraco A. G., Lee E. J., Orme I. M., Gonzalez-Juarrero M., Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection. Tuberculosis 2009 89 2 149 157 2-s2.0-61649094923 10.1016/j.tube.2009.01.001
189. Toossi Z., Gogate P., Shiratsuchi H., Young T., Ellner J. J., Enhanced production of TGF- β by blood monocytes from patients with active tuberculosis and presence of TGF- β in tuberculous granulomatous lung lesions. Journal of Immunology 1995 154 1 465 473 2-s2.0-0028984644
190. Dahl K. E., Shiratsuchi H., Hamilton B. D., Ellner J. J., Toossi Z., Selective induction of transforming growth factor β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infection and Immunity 1996 64 2 399 405 2-s2.0-0030033026 (Pubitemid 26032807)
191. Ding A., Nathan C. F., Graycar J., Derynck R., Stuehr D. J., Srimal S., Macrophage deactivating factor and transforming growth factors- β 1,-β 2, and-β 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN- γ Journal of Immunology 1990 145 3 940 944 2-s2.0-0025311615 (Pubitemid 20231287)
192. + T-cell responses to Mycobacterium tuberculosis by interleukin-10 and transforming growth factor β Infection and Immunity 1999 67 12 6461 6472 2-s2.0-0032702441
193. Ruscetti F., Varesio L., Ochoa A., Ortaldo J., Pleiotropic effects of transforming growth factor- β on cells of the immune system. Annals of the New York Academy of Sciences 1993 685 488 500 2-s2.0-0027213710 (Pubitemid 23238531)
194. Hirsch C. S., Ellner J. J., Blinkhorn R., Toossi Z., In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor β Proceedings of the National Academy of Sciences of the United States of America 1997 94 8 3926 3931 2-s2.0-0030890711 10.1073/pnas.94.8.3926 (Pubitemid 27180475)
195. Desvignes L., Wolf A. J., Ernst J. D., Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. Journal of Immunology 2012 188 12 6205 6215
196. Stern J. N. H., Keskin D. B., Romero V., Zuniga J., Encinales L., Li C., Awad C., Yunis E. J., Molecular signatures distinguishing active from latent tuberculosis in peripheral blood mononuclear cells, after in vitro antigenic stimulation with purified protein derivative of tuberculin (PPD) or Candida: a preliminary report. Immunologic Research 2009 45 1 1 12 2-s2.0-70349593476 10.1007/s12026-008-8024-2
197. Berry M. P. R., Graham C. M., McNab F. W., Xu Z., Bloch S. A. A., Oni T., Wilkinson K. A., Banchereau R., Skinner J., Wilkinson R. J., Quinn C., Blankenship D., Dhawan R., Cush J. J., Mejias A., Ramilo O., Kon O. M., Pascual V., Banchereau J., Chaussabel D., O'Garra A., An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010 466 7309 973 977 2-s2.0-77955894773 10.1038/nature09247
198. McNab F. W., Ewbank J., Rajsbaum R., TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production. Journal of Immunology 2013 191 4 1732 1743 10.4049/jimmunol.1300146
199. Giosuè S., Casarini M., Alemanno L., Galluccio G., Mattia P., Pedicelli G., Rebek L., Bisetti A., Ameglio F., Effects of aerosolized interferon- α in patients with pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine 1998 158 4 1156 1162 2-s2.0-0031796534 (Pubitemid 28489016)
200. Palmero D. J., Eiguchi K., Rendo P., Castro Zorrilla L., Abbate E., González Montaner L. J., Phase II trial of recombinant interferon- α 2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up. International Journal of Tuberculosis and Lung Disease 1999 3 3 214 218 2-s2.0-0033067896 (Pubitemid 29133046)
201. Ward C. M., Jyonouchi H., Kotenko S. V., Smirnov S. V., Patel R., Aguila H., McSherry G., Dashefsky B., Holland S. M., Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. European Journal of Pediatrics 2007 166 9 981 985 2-s2.0-34547129317 10.1007/s00431-006-0339-1 (Pubitemid 47101344)
202. Telesca C., Angelico M., Piccolo P., Nosotti L., Morrone A., Longhi C., Carbone M., Baiocchi L., Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant. Journal of Infection 2007 54 4 e223 e226 2-s2.0-33947206161 10.1016/j.jinf.2006.12.009 (Pubitemid 46420105)
203. Redford P. S., Mayer-Barber K. D., McNab F. W., Stavropoulos E., Wack A., Sher A., O'Garra A., Influenza A virus impairs control of Mycobacterium tuberculosis co-infection through a type I interferon receptor dependent pathway. The Journal of Infectious Diseases 2013 10.1093/infdis/jit424
204. Bouchonnet F., Boechat N., Bonay M., Hance A. J., Alpha/beta interferon impairs the ability of human macrophages to control growth of Mycobacterium bovis BCG. Infection and Immunity 2002 70 6 3020 3025 2-s2.0-0036259829 10.1128/IAI.70.6.3020-3025.2002 (Pubitemid 34564162)
205. Giacomini E., Remoli M. E., Gafa V., Pardini M., Fattorini L., Coccia E. M., IFN- β improves BCG immunogenicity by acting on DC maturation. Journal of Leukocyte Biology 2009 85 3 462 468 2-s2.0-61449109077 10.1189/jlb.0908583
206. Novikov A., Cardone M., Thompson R., Shenderov K., Kirschman K. D., Mayer-Barber K. D., Myers T. G., Rabin R. L., Trinchieri G., Sher A., Feng C. G., Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1 β production in human macrophages. Journal of Immunology 2011 187 5 2540 2547 2-s2.0-80052669048 10.4049/jimmunol.1100926
207. Mayer-Barber K. D., Andrade B. B., Barber D. L., Hieny S., Feng C. G., Caspar P., Oland S., Gordon S., Sher A., Innate and adaptive interferons suppress IL-1 α and IL-1 β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection. Immunity 2011 35 6 1023 1034 2-s2.0-84255162073 10.1016/j.immuni.2011.12.002
208. Denis M., Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection. Infection and Immunity 1991 59 5 1857 1859 2-s2.0-0025756043
209. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J. M., Barry C. E. III, Freedman V. H., Kaplan G., Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN- α / β Proceedings of the National Academy of Sciences of the United States of America 2001 98 10 5752 5757 2-s2.0-0035826721 10.1073/pnas.091096998 (Pubitemid 32435714)
210. Kuchtey J., Fulton S. A., Reba S. M., Harding C. V., Boom W. H., Interferon- α β mediates partial control of early pulmonary Mycobacterium bovis bacillus Calmette-Guérin infection. Immunology 2006 118 1 39 49 2-s2.0-33645829064 10.1111/j.1365-2567.2006.02337.x
211. Ordway D., Henao-Tamayo M., Harton M., Palanisamy G., Troudt J., Shanley C., Basaraba R. J., Orme I. M., The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation. Journal of Immunology 2007 179 1 522 531 2-s2.0-34250794992 (Pubitemid 46986569)
212. Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., Förster I., Farlik M., Decker T., Du Pasquier R. A., Romero P., Tschopp J., Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity 2011 34 2 213 223 2-s2.0-79951740151 10.1016/j.immuni.2011.02.006
213. Ho H. H., Ivashkiv L. B., Role of STAT3 in type I interferon responses: negative regulation of STAT1-dependent inflammatory gene activation. Journal of Biological Chemistry 2006 281 20 14111 14118 2-s2.0-33744920357 10.1074/jbc.M511797200 (Pubitemid 43848338)